Popular Articles
Revitol Cellulite Cream

Informa Announces A New Award For Best Review Paper
The editors of Disability & Rehabilitation and its sister publication, Disability & Rehabilitation: Assistive Technology have announced an annual award which will be given for the best review paper published in either of the two journals. Commencing in 2009, the Informa Best Review Paper Award will recognise valuable, high-impact research in the fields of disability, rehabilitation and assistive technology. Don't forget to buy zoloft online no prescription.

New Data Show Cost Savings Achieved By Treating Mild And Moderate Alzheimer's Patients With Aricept(R)
Researchers attending the annual meeting of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), heard today that prescribing Aricept® (donepezil hydrochloride) as soon as patients are diagnosed with either mild or moderate Alzheimer"s disease saves the NHS money. The findings contradict the recommendation by NICE that these medicines are not cost effective in the early stages of the disease, a decision that has been the subject of much recent debate.

generic viagra online


News of the day
Rolofylline Did Not Demonstrate Efficacy For Acute Heart Failure In Clinical Trial
Merck & Co., Inc. said that preliminary results for the pivotal Phase III study of rolofylline (MK-7418), the Company"s investigational medicine for the treatment of acute heart failure, show that rolofylline did not meet the primary or secondary efficacy endpoints. While Merck will continue to analyze the data with outside experts, the Company will not file applications for regulatory approval this year. The results from this study will be presented at a medical meeting later this year.
Health Insurance

30% Of Children At Risk Of Future Heart Disease

Almost 30% of 14-year-old Australian children fall within a group identified as being at future increased risk of heart disease, type 2 diabetes or stroke, according to results referred to in the Medical Journal of Australia. West Australian researchers, including Professor Fiona Stanley of the Telethon Institute for Childhood Health Research, identified children at risk of future cardiovascular disease with features of metabolic syndrome. Metabolic syndrome is a collection of disorders which increases the risk of heart disease, type 2 diabetes and stroke. "We found that 29% of children were in the high-risk category at the age of 14 years. Even at the age of eight years, 25 per cent of children were at increased risk of future obesity, cardiovascular disease and diabetes," Dr Rae-Chi Huang, from the University of Western Australia said. "The magnitude of this problem - which affects up to a third of our youth - needs to be urgently addressed by governments and health planning bodies." In the same edition of the Medical Journal of Australia, data was presented from the three most recent national surveys in which the weight and height of Australian children was measured. The data showed that the proportion of boys aged 7-15 years who were overweight or obese more than doubled from 11% in 1985 to 23.7% in 2007. The proportion of girls aged 7 -15 years who were obese or overweight also more than doubled from 12.2% in 1985 to 25.8% in 2007. "This trend is a cause for alarm, given the widely-recognised body of evidence on the significant short-term and long-term consequences of childhood obesity," co-author and Heart Foundation CEO-National Dr Lyn Roberts said. The Medical Journal of Australia is a publication of the Australian Medical Association. Australian Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):